13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)

Page 5 of 9 – SEC Filing

 

CUSIP
No
.
713661502   Page
5 of 9

 

1

NAME
OF REPORTING PERSONS
Prasad Phatak

 

I.R.S.
IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY)

 
2 CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)

(b)

3 SEC
USE ONLY
 
4

CITIZENSHIP
OR PLACE OF ORGANIZATION

United
States of America

 

NUMBER
OF
SHARES

BENEFICIALLY
OWNED BY

EACH
REPORTING

PERSON
WITH:

5

SOLE
VOTING POWER

67,107

 
6

SHARED
VOTING POWER

2,231,577*

 
7

SOLE
DISPOSITIVE POWER

67,107

 
8

SHARED
DISPOSITIVE POWER

2,231,577*

 
9

AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,298,684*

 
10 CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
11

PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9

5.10%†

 
12

TYPE
OF REPORTING PERSON

IN

 
         

*
Mr. Phatak is the managing member of Tappan Street Partners LLC. As a result, Mr. Phatak possesses the power to vote and dispose
or direct the disposition of all the shares beneficially owned by Tappan Street Partners LLC as investment manager to the Funds.
Mr. Phatak disclaims beneficial ownership of any of the shares held by the Funds.

 

 

†Based
on a total of 45,069,188 Shares outstanding of the Issuer as of July 11, 2017, as set forth in the Issuer’s most recent
Form 10-K, filed July 14, 2017.

Follow Avid Bioservices Inc. (NASDAQ:CDMO)